790 related articles for article (PubMed ID: 34533882)
1. Gut-liver axis-mediated mechanism of liver cancer: A special focus on the role of gut microbiota.
Ohtani N; Hara E
Cancer Sci; 2021 Nov; 112(11):4433-4443. PubMed ID: 34533882
[TBL] [Abstract][Full Text] [Related]
2. Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE
Loo TM; Kamachi F; Watanabe Y; Yoshimoto S; Kanda H; Arai Y; Nakajima-Takagi Y; Iwama A; Koga T; Sugimoto Y; Ozawa T; Nakamura M; Kumagai M; Watashi K; Taketo MM; Aoki T; Narumiya S; Oshima M; Arita M; Hara E; Ohtani N
Cancer Discov; 2017 May; 7(5):522-538. PubMed ID: 28202625
[TBL] [Abstract][Full Text] [Related]
3. The Gut-Liver Axis in Health and Disease: The Role of Gut Microbiota-Derived Signals in Liver Injury and Regeneration.
Zheng Z; Wang B
Front Immunol; 2021; 12():775526. PubMed ID: 34956204
[TBL] [Abstract][Full Text] [Related]
4. Interactions between gut microbiota and non-alcoholic liver disease: The role of microbiota-derived metabolites.
Ding Y; Yanagi K; Cheng C; Alaniz RC; Lee K; Jayaraman A
Pharmacol Res; 2019 Mar; 141():521-529. PubMed ID: 30660825
[TBL] [Abstract][Full Text] [Related]
5. The gut microbiome-bile acid axis in hepatocarcinogenesis.
Wu L; Feng J; Li J; Yu Q; Ji J; Wu J; Dai W; Guo C
Biomed Pharmacother; 2021 Jan; 133():111036. PubMed ID: 33378947
[TBL] [Abstract][Full Text] [Related]
6. Dietary Fiber from Oat and Rye Brans Ameliorate Western Diet-Induced Body Weight Gain and Hepatic Inflammation by the Modulation of Short-Chain Fatty Acids, Bile Acids, and Tryptophan Metabolism.
Kundi ZM; Lee JC; Pihlajamäki J; Chan CB; Leung KS; So SSY; Nordlund E; Kolehmainen M; El-Nezami H
Mol Nutr Food Res; 2021 Jan; 65(1):e1900580. PubMed ID: 32526796
[TBL] [Abstract][Full Text] [Related]
7. The role of gut microbiota in liver regeneration.
Xu Z; Jiang N; Xiao Y; Yuan K; Wang Z
Front Immunol; 2022; 13():1003376. PubMed ID: 36389782
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin prevents fermentable fiber-induced liver cancer in mice with dysbiotic gut microbiota.
Singh V; Yeoh BS; Abokor AA; Golonka RM; Tian Y; Patterson AD; Joe B; Heikenwalder M; Vijay-Kumar M
Gut Microbes; 2020 Jul; 11(4):1077-1091. PubMed ID: 32223398
[TBL] [Abstract][Full Text] [Related]
9. The role of the gut microbiota in NAFLD.
Leung C; Rivera L; Furness JB; Angus PW
Nat Rev Gastroenterol Hepatol; 2016 Jul; 13(7):412-25. PubMed ID: 27273168
[TBL] [Abstract][Full Text] [Related]
10. Role of gut microbial metabolites in nonalcoholic fatty liver disease.
Zhao ZH; Lai JK; Qiao L; Fan JG
J Dig Dis; 2019 Apr; 20(4):181-188. PubMed ID: 30706694
[TBL] [Abstract][Full Text] [Related]
11. Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis.
de Faria Ghetti F; Oliveira DG; de Oliveira JM; de Castro Ferreira LEVV; Cesar DE; Moreira APB
Eur J Nutr; 2018 Apr; 57(3):861-876. PubMed ID: 28875318
[TBL] [Abstract][Full Text] [Related]
12. The role of immune cells in the liver tumor microenvironment: an involvement of gut microbiota-derived factors.
Kamiya T; Ohtani N
Int Immunol; 2022 Sep; 34(9):467-474. PubMed ID: 35652367
[TBL] [Abstract][Full Text] [Related]
13. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
Rizzetto L; Fava F; Tuohy KM; Selmi C
J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
[TBL] [Abstract][Full Text] [Related]
14. The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases.
Hosseinkhani F; Heinken A; Thiele I; Lindenburg PW; Harms AC; Hankemeier T
Gut Microbes; 2021; 13(1):1-22. PubMed ID: 33590776
[TBL] [Abstract][Full Text] [Related]
15. Gut-liver axis in the progression of nonalcoholic fatty liver disease: From the microbial derivatives-centered perspective.
Luo L; Chang Y; Sheng L
Life Sci; 2023 May; 321():121614. PubMed ID: 36965522
[TBL] [Abstract][Full Text] [Related]
16. [The gut-liver axis: how the gut promotes liver disease].
Demir M; Tacke F
Inn Med (Heidelb); 2022 Oct; 63(10):1028-1035. PubMed ID: 36053302
[TBL] [Abstract][Full Text] [Related]
17. Gut Microbiota-Derived Components and Metabolites in the Progression of Non-Alcoholic Fatty Liver Disease (NAFLD).
Ji Y; Yin Y; Li Z; Zhang W
Nutrients; 2019 Jul; 11(8):. PubMed ID: 31349604
[TBL] [Abstract][Full Text] [Related]
18. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome.
Yoshimoto S; Loo TM; Atarashi K; Kanda H; Sato S; Oyadomari S; Iwakura Y; Oshima K; Morita H; Hattori M; Honda K; Ishikawa Y; Hara E; Ohtani N
Nature; 2013 Jul; 499(7456):97-101. PubMed ID: 23803760
[TBL] [Abstract][Full Text] [Related]
19. Microbial metabolites as modulators of host physiology.
Joyce SA; Clarke DJ
Adv Microb Physiol; 2024; 84():83-133. PubMed ID: 38821635
[TBL] [Abstract][Full Text] [Related]
20. Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice.
Zheng X; Huang F; Zhao A; Lei S; Zhang Y; Xie G; Chen T; Qu C; Rajani C; Dong B; Li D; Jia W
BMC Biol; 2017 Dec; 15(1):120. PubMed ID: 29241453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]